{"id":"768792210017-73","name":"European Biopharmaceutical Enterprises","registrationDate":"2012-10-30T12:26:12.250+02:00","category":2,"subCategory":4,"legal":"a specialised group within the European Federation of Pharmaceutical Industries and Associations (EFPIA)","web":"http://www.ebe-biopharma.eu","country":"Belgium","headAddress":"rue du Trône, 108","headCity":"Bruxelles","headPostCode":"1050","headPhone":"(32)6 26 25 55","boss":"Nathalie Moll","bossTitle":"Ms","bossPosition":"EFPIA Director General","membersCount":3,"membersFTE":"1.0","membership":"EBE operates as a specialised group within the European Federation of Pharmaceutical Industries and Associations – EFPIA-, which operates as the representative organisation of the pharmaceutical industry in Europe. EBE is a member of the European Alliance for Personalised Medicines (EAPM).","memberOrga":"https://www.ebe-biopharma.eu/membership/  - &#xd;\nAt the time of the annual update in 2018, EBE had 54 member entities, two of which are affiliate organisations. One of these is a national association, the others are companies.","goal":"The mission of “European Biopharmaceutical Enterprises” (EBE) is to: &#xd;<br />&#xd;<br />Represent biopharmaceutical companies of all sizes operating in Europe in the formulation of policies at global and European levels.&#xd;<br />&#xd;<br />Focus on enhancing emerging healthcare technologies and promoting science innovation in Europe via expertise in:&#xd;<br />•\tInnovation eco-system and funding models&#xd;<br />•\tEmerging biotech &amp; science - regulatory advancement and advocacy&#xd;<br />&#xd;<br />Contribute industry expertise to the development of new regulatory frameworks, guidelines and standards of relevance to biopharmaceuticals.&#xd;<br />&#xd;<br />Promote the exchange of good practices to foster the development of safe, efficacious and high-quality medicines.&#xd;<br />&#xd;<br />Increase awareness of the sector, its products and the tangible benefits that biopharmaceuticals bring to patients and society worldwide.&#xd;<br />&#xd;<br />Support the business development of member companies, especially SMEs, through advice, networking, training and educational opportunities.&#xd;<br />&#xd;<br />Facilitate information exchange and communications between all stakeholders within the field of biopharmaceuticals through EBE acting as resource centre.&#xd;<br />&#xd;<br />&#xd;<br />Goal A – Public Affairs&#xd;<br />To represent the research-based biopharmaceutical industry operating in Europe in the promotion and formulation of policies creating a favourable scientific, business and regulatory environment, thanks to building and communicating common industry positions through direct representation to key stakeholders at European and global levels.&#xd;<br />&#xd;<br />Goal B – Regulatory &amp; Technical Affairs&#xd;<br />To contribute industry expertise to the development of new regulatory frameworks, guidelines and standards of relevance to biopharmaceutical companies operating in Europe and to promote the exchange of good practices fostering the development of safe, efficacious and high-quality medicines. &#xd;<br />&#xd;<br />Goal C – Business Development Support Services&#xd;<br />To support the business development of member companies, especially small &amp; medium-sized enterprises, through the provision of quality membership services including advice, networking, training and educational opportunities.&#xd;<br />&#xd;<br />Goal D – Information and Communication&#xd;<br />To increase awareness of the industry sector, its products and the tangible benefits that biopharmaceuticals bring to patients and society worldwide. Facilitate information exchange and communications between all stakeholders in the biopharmaceuticals field through EBE acting as resource centre.&#xd;<br />&#xd;<br />Goal E – Membership Growth&#xd;<br />To continuously develop a strong membership base composed of large pharmaceutical corporations, biotechnology companies and SMEs that will strengthen the sector’s representation and the association’s expertise &amp; influence in Europe and further afield.","acronym":"EBE","interests":"Audiovisual and Media, Communication, Competition, Consumer Affairs, Development, Education, Employment and Social Affairs, Enterprise, Environment, External Relations, Financial Stability, Financial Services and Capital Markets Union , General and Institutional Affairs, Information Society, Internal Market, Public Health, Research and Technology, Trade, Trans-European Networks","euInitiatives":"EBE tracks and provides input as required on all EU policy initiatives and legislation relating to therapeutic biological medicinal products, advanced therapies, and personalised medicines as well as supporting a viable environment for innovative SMEs in biopharma.","lastUp":"2018-04-11T14:34:59.075+02:00","customers":"","costAbsolu":"","costRange":"100000-199999","turnoverAbsolu":0,"turnoverRange":""}